Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX
Industry leading set of technologies to drive scalability, flexibility, and efficiency in biologics production RADNOR, Pa., April 1, 2025 /PRNewswire/...
Pharmaceutical
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC
News Summary Boosts out-of-the-box sensitivity by up to 80 times with MaxPeakTM Premier columns.1Delivers over threefold improvements in day-to-day reproducibility2...
ixlayer and Ipsos’ “ixInsights 2025” Study Reveals Consumer Expectations for Digital Health and Pharma’s Role in Enhancing Patient Experience
Study Captures Drivers and Deterrents to Digital Health to Inform Biopharma Cx, Commercialization and Marketing Efforts SAN FRANCISCO, April 1,...
Veeva Announces Research Site Clinical Trial Management System
Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors PLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva...
EVERSANA Joins Veeva AI Partner Program
Program partner to develop GenAI solutions that seamlessly integrate with Veeva applications CHICAGO, April 1, 2025 /PRNewswire/ -- EVERSANA, a...
Policy Reporter by Mercalis and AccessSync Announce Strategic Partnership to Transform Market Access Capabilities
Collaboration integrates comprehensive payer policy intelligence with Access Realization™ solutions to overcome market access complexity for life sciences products MORRISVILLE,...
Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart
– FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD...
GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen...
ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®
BURNABY, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Telix ARTMS, Inc. (ARTMS), a global leader in radioisotope production technologies,...
Updated biographies for board candidates at the upcoming Annual General Meeting
1 April 2025Announcement no. 8 Updated biographies for board candidates at the upcoming Annual General Meeting Copenhagen, Denmark, April 1,...
Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial
– Initial data readout on track for second half of 2025 HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech,...
Clene to Present at the Jones Healthcare and Technology Innovation Conference
SALT LAKE CITY, April 01, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its...
Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025
Solengepras showed evidence of potential benefit in functional and non-motor symptoms versus placebo as measured by MDS-UPRDS Parts I, II,...
Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment
The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals...
Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress
CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering...
Nkarta to Participate in an April Investor Conference
SOUTH SAN FRANCISCO, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural...
Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients
Data published in Neuro-Oncology demonstrate promising safety profile and potential survival benefit when combining CAN-2409 and nivolumab with standard of...
Phathom Pharmaceuticals Announces Leadership Succession
FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing...
Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes
– Remaining $60 Million of outstanding convertible notes to be repurchased post-close of pending UDENYCA divestiture – REDWOOD CITY, Calif.,...
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
DUBLIN, April 01, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to...